WASHINGTON, March 29, 2016 -- The Center for Information and Study on Clinical Research Participation (CISCRP) is pleased to announce its second AWARE for All event in the D.C. metropolitan area on April 20, 2016. This free program is designed to improve understanding about clinical research participation and promote dialogue by connecting patients, researchers, and members of the general public in the local community.
The event will be hosted at Howard University's Blackburn Center on Wednesday, April 20 from 5 to 8 p.m. in collaboration with Howard University, Howard University Hospital and Georgetown-Howard Universities Center for Clinical and Transitional Science (GHUCCTS). This program will feature free health screenings, informational exhibits, meaningful presentations from prominent D.C. medical professionals and researchers about various health conditions, and local patients involved in clinical research, as well as refreshments and prizes. Funding for this event is provided by PhRMA, EMD Serono, Howard University, Lupus Research Institute, Optimal Research, and other local and national health and advocacy organizations.
"The discovery of new treatments is not possible without volunteers participating in clinical research," said Jocelyn Ulrich, Assistant Vice President, Science and Regulatory Advocacy, PhRMA. "For this reason, it is critical to both educate the public about clinical research and celebrate those who have participated. AWARE for All is an opportunity for this type of community education and engagement, and we're proud to be sponsoring the program for a second year."
|
|||||
CISCRP has held more than 50 of these AWARE for All Clinical Research Education Events in cities around the world, bringing communities together in each destination for important conversations about clinical research and the important role it plays in each of our lives.
"There is a need for general education about the clinical research process including the risks, benefits, and the rights of participants. Ultimately, CISCRP hopes to empower patients and the public to make informed decisions about clinical research." explained Ken Getz, Founder and Chairman of the Board at CISCRP.
AWARE for All is a free event is open to the public; however, advanced registration is strongly encouraged through www.awareforall.org or by calling 1-877-MED-HERO (1-877-633-4370).
ABOUT CISCRP:
The Center for Information and Study (CISCRP) is a 501(c)(3) non-profit organization dedicated to engaging the public and patients as partners in the clinical research process. CISCRP provides free education and outreach to the general public and patient communities. Visit www.CISCRP.org for more information or to support CISCRP's educational initiatives.
Editor's Note
Community partners include: the Arthritis Foundation, Association of Clinical Research Professionals, Bristol-Myers Squibb, Cancer Support Community, Emerson Clinical Research, Familia Con Diabetes, FDA Office of Minority Health, Fuerza Contra Alzheimer's, Georgetown University School of Nursing, The George Washington University School of Medicine and Health Sciences, HealthiVibe, Howard University Clinical Research Unit (CRU), Hudson Global, the Leukemia & Lymphoma Society, Lupus Research Institute, Men's Health Network, The National Coalition for Women with Heart Disease (WomenHeart), Parkinson's Disease Foundation, PhRMA, Society for Women's Health Research, US Against Alzheimer's, and Whitman Walker- AIDS Clinical Trials Group.
A photo accompanying this release is available at: http://www.globenewswire.com/newsroom/prs/?pkgid=39613
CONTACT: Danielle Lavieri, CISCRP
Phone: 617-725-2750
[email protected]


Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Nintendo Shares Slide After Earnings Miss Raises Switch 2 Margin Concerns
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised 



